This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
the percentage of current delays by intervals of 60 minutes; the percentage of delays after a campaign by intervals of 60 minutes; the percentage of thrombolytic therapies by intervals of 60 minutes; mortality reduction due to thrombolytic therapy as a function of delay; the occurrence of AMI in Denmark; the effect of pre-hospital telemedicine diagnosis; and life expectancy after the first month after AMI.
Study designs and other criteria for inclusion in the review
Not reported.
Sources searched to identify primary studies
MEDLINE was searched for primary studies.
Criteria used to ensure the validity of primary studies
Methods used to judge relevance and validity, and for extracting data
Number of primary studies included
Approximately nine primary studies were included in the review.
Methods of combining primary studies
The primary studies do not appear to have been combined.
Investigation of differences between primary studies
The differences between the primary studies were not reported and were not investigated.
Results of the review
In Denmark, 34% of patients with AMI arrive at hospital within 2 hours after the onset of symptoms and 81% arrive within 12 hours. Seven per cent are admitted within 1 hour after the onset of symptoms. Door-to-needle delay was 60 minutes. Presentation delay was presented in full in the paper, for hourly increments over a 24-hour period.
Twenty-one per cent of patients older than 65 years and 8% of those older than 75 years have thrombolytic therapy.
The additional benefit of combining pre-hospital telemedicine diagnostics with a public campaign reduced door-toneedle delay by 50%.
Thirty-two per cent of patients with suspected AMI call the emergency phone number and are transported by ambulance, while 64% contact a general practitioner. Of the latter, 80% are transferred by ambulance to hospital.
The estimated cost of pre-hospital telemedicine diagnostics was DKK 304.8 million (285.5 million after discounting at 5%).
Synthesis of costs and benefits
The costs and benefits were combined by calculating the cost per LYG.
The cost of the pubic campaign per LYG was DKK 161,459 (283,304 after discounting both life years and costs).
If the public campaign was combined with pre-hospital telemedicine diagnostics, the cost per LYG would be DKK 321,440 (DKK 563,771 after discounting).
The marginal cost per LYG of adding the telemedicine strategy to the public campaign was DKK 854,700 (discounted).
In the sensitivity analysis, assuming that 25% patients with non-cardiac chest pain in the emergency department would be admitted to the cardiology department, the cost per LYG would increase by 103% to DKK 577,000.
With a reduction in the cost of information material from DKK 40 million to DKK 20 million , the cost per LYG decreased by 40% to DKK 170,000.
When assuming a different age distribution among those having thrombolysis (more elderly treated), the cost per LYG was DKK 346,000.
Realistic changes in other parameters were reported to have little influence on the cost-effectiveness ratio.
